4th Quarter - Amendment
PHARMATHENE, INC for PHARMATHENE, INC
Firm
Client
Income
—
Expenses
$177,760
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Biodefense Advanced Research and Development funding for BARDA/HHS. Economic Stimulus/Recovery funding for HHS, BARDA and NIH to supprt advanced R&D for biodefense vaccines and therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK EDWARD COOKE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.